Test Bank For Abrams’ Clinical Drug Therapy Rationales for Nursing Practice 12th Edition (Geralyn Frandsen,
2024) All Chapters 1-56 , Latest Guide
... [Show More] A+.
Chapter 1 : The Foundation of Pharmacology: Quality and Safety :
1.A woman diagnosed with obsessive–compulsive disorder has been prescribed oral paroxetine hydrochloride.
What is the expected effect for this prescription?
A. Curative effect on symptoms
B. Systemic effect on symptoms
C. Local effect on symptoms
D. Parenteral effect on symptoms
ANS: B
Rationale: Drugs that produce systemic effects are taken into the body, circulated through the
bloodstream to their sites of action in various body tissues, and eventually eliminated from the body.
Curative agents are given to cure a disease process. In this case, paroxetine hydrochloride will control
the symptoms but not cure the disorder. Drugs with local effects, such as sunscreen and local
anesthetics, act mainly at the site of application. Paroxetine hydrochloride is not administered
parenterally. Parenteral agents are administered subcutaneously, intramuscularly, or intravenously.
PTS: 1 REF: p. 3, Introduction OBJ: 1
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies
TOP: Chapter: 1: The Foundation of Pharmacology: Quality and Safety
KEY: Integrated Process: Nursing Process
BLM: Cognitive Level: Understand NOT: Multiple Choice
2. A client has been prescribed an antibiotic. This medication is a naturally occurring substance that has
been chemically modified. What is another name for this type of medication?
A. Synthetic drug
B. Semisynthetic drug
C. Biotechnology drug
D. Prototype drug
ANS: B
Rationale: Semisynthetic drugs (e.g., many antibiotics) are naturally occurring substances that have
been chemically modified. Synthetic drugs are more standardized in their chemical characteristics,
more consistent in their effects, and less likely to produce allergic reactions. Biotechnology drugs
involve manipulating DNA and RNA and recombining genes into hybrid molecules that can be
inserted into living organisms. Prototype drugs are the first drug of a particular group to be developed.
PTS: 1 REF: p. 3, Drug Sources OBJ: 1
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies
TOP: Chapter: 1: The Foundation of Pharmacology: Quality and Safety
KEY: Integrated Process: Nursing Process
BLM: Cognitive Level: Understand NOT: Multiple Choice
3. Which classification applies to morphine?
A. Central nervous system depressant
B. Central nervous system stimulant
C. Anti-inflammatory
D. Antihypertensive
ANS: A
Rationale: Drugs are classified according to their effects on particular body systems, their therapeutic
uses, and their chemical characteristics. Morphine is classified as a central nervous system depressant
and will produce this effect in the client. A central nervous system stimulant increases attention and
raises mood. An anti-inflammatory agent decreases inflammation at the site of tissue or joint
inflammation. An antihypertensive agent reduces blood pressure.
PTS: 1 REF: p. 3, Drug Classifications and Prototypes
OBJ: 1
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies
TOP: Chapter: 1: The Foundation of Pharmacology: Quality and Safety
KEY: Integrated Process: Nursing Process
BLM: Cognitive Level: Remember NOT: Multiple Choice
4. A client is administered amoxicillin. The generic name of this medication belongs to which drug
group?
A. Selective serotonin reuptake inhibitors
B. Diuretics
C. Penicillins
D. ACE inhibitors
ANS: C
Rationale: The generic name often indicates the drug group (e.g., drugs with generic names ending in
“cillin” are penicillins). Selective serotonin reuptake inhibitors are medications that have
antidepressant effects; SSRI is a broad classification, not a generic name. Diuretics are medications
that increase urine output; diuretic is a broad classification, not a generic name. ACE inhibitor is the
broad classification for the angiotensin receptor blockers, not the generic name.
PTS: 1 REF: p. 3, Drug Names OBJ: 2
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies
TOP: Chapter: 1: The Foundation of Pharmacology: Quality and Safety
KEY: Integrated Process: Nursing Process
BLM: Cognitive Level: Understand NOT: Multiple Choice
5. The administration of diphenhydramine is regulated by which U.S. government agency?
A. Public Health Service
B. Federal Trade Commission
C. Occupational Safety and Health Administration
D. Food and Drug Administration
ANS: D
Rationale: The Food and Drug Administration approves drugs for over-the-counter availability,
including the transfer of drugs from prescription to OTC status, and may require clinical trials to
determine the safety and effectiveness of OTC use. The Public Health Service is regulated by the state
to maintain the health of individual citizens of the state. The Federal Trade Commission regulates
imports and exports throughout the nation. The Occupational Safety and Health Administration
regulates safety within the workplace.
PTS: 1 REF: p. 4, Prescription and Nonprescription Drugs
OBJ: 4
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies
TOP: Chapter: 1: The Foundation of Pharmacology: Quality and Safety
KEY: Integrated Process: Nursing Process
BLM: Cognitive Level: Understand NOT: Multiple Choice
6. In the U.S., the administration of anabolic steroids is regulated by which law?
A. The Food, Drug, and Cosmetic Act of 1938
B. The Comprehensive Drug Abuse Prevention and Control Act
C. The Harrison Narcotic Act
D. The Sherley Amendment
ANS: B
Rationale: The Comprehensive Drug Abuse Prevention and Control Act regulates the manufacture and
distribution of narcotics, stimulants, depressants, hallucinogens, and anabolic steroids. The Food,
Drug, and Cosmetic Act of 1938 revised and broadened FDA powers and responsibilities, giving the
FDA control over drug safety. The Harrison Narcotic Act restricted the importation, manufacture, sale,
and use of opium, cocaine, marijuana, and other drugs that the act defined as narcotics. The Sherley
Amendment of 1912 prohibited fraudulent claims of drug effectiveness.
PTS: 1 REF: p. 4, Prescription and Nonprescription Drugs
OBJ: 3
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies
TOP: Chapter: 1: The Foundation of Pharmacology: Quality and Safety
KEY: Integrated Process: Nursing Process
BLM: Cognitive Level: Remember NOT: Multiple Choice
7. A nurse is responsible for maintaining an accurate count and record of the controlled substances on the
nursing division. This nursing action is regulated by which U.S. law or agency?
A. The Food, Drug, and Cosmetic Act of 1938
B. The Public Health Service
C. The Drug Enforcement Administration
D. The Sherley Amendment
ANS: C
Rationale: The Drug Enforcement Administration enforces the Controlled Substances Act. Under this
enforcement, nurses are responsible for storing controlled substances in locked containers,
administering them only to the people for whom they are prescribed, recording each dose given, and
maintaining an accurate inventory. The Food, Drug, and Cosmetic Act of 1938 revised and broadened
FDA powers and responsibilities, giving the FDA control over drug safety. The Public Health Service
is regulated by the state to maintain the health of individual citizens of the state. The Sherley
Amendment of 1912 prohibited fraudulent claims of drug effectiveness.
PTS: 1 REF: p. 7, Testing Procedure OBJ: 4
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies
TOP: Chapter: 1: The Foundation of Pharmacology: Quality and Safety
KEY: Integrated Process: Nursing Process
BLM: Cognitive Level: Understand NOT: Multiple Choice
8. In Phase 1 clinical trials, the potential uses and effects of a new drug are determined by which method?
A. Administering doses to healthy volunteers
B. Administering doses to people with the disease
C. Administering in placebo-controlled design
D. Calculating the risk-to-benefit ratio
ANS: A
Rationale: Phase 1 studies allow for the administration of the medication to healthy volunteers to
determine safe dosages, routes of administration, absorption, metabolism, excretion, and toxicity. In
Phase 2 studies, a few doses are given to a certain number of subjects with the disease or symptom for
which the drug is being studied and responses are compared with those of healthy subjects. Placebocontrolled designs are used in Phase 3 studies, in which half of the subjects receive the new drug and
half receive the placebo. Calculating the risk-to-benefit ratio is used in Phase 2 studies to determine
whether the potential benefits of the drug outweigh the risks.
PTS: 1 REF: p. 7, Testing Procedure OBJ: 5
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies
TOP: Chapter: 1: The Foundation of Pharmacology: Quality and Safety
KEY: Integrated Process: Nursing Process
BLM: Cognitive Level: Understand NOT: Multiple Choice
9. A new medication for the treatment of Alzheimer’s disease is being administered to a group of subjects
with the disease. The subjects receiving this medication are unaware of whether they are being
administered the medication or a placebo. This testing occurs in which phase?
A. Phase 1
B. Phase 2
C. Phase 3
D. Phase 4
ANS: C
Rationale: In Phase 3, the drug is given to a larger and more representative group of subjects. In
double-blind, placebo-controlled designs, half of the subjects receive the new drug and half receive a
placebo (an inactive substance similar in appearance to the actual drug), with neither subjects nor
researchers knowing which subjects receive which formulation. In Phase 1, a few doses are given to a
certain number of healthy volunteers to determine safe dosages, routes of administration, absorption,
metabolism, excretion, and toxicity. In Phase 2, a few doses are given to a certain number of subjects
with the disease or symptom for which the drug is being studied and responses are compared with
those of healthy subjects. In Phase 4, the FDA evaluates the data from the first three phases for drug
safety and effectiveness, allows the drug to be marketed for general use, and requires manufacturers to
continue monitoring the drug’s effects. [Show Less]